Синдром Гийена-Барре и беременность: диагностика и особенности ведения (клиническое наблюдение)
Хакимова Альбина Раисовна, Н. А. Попова, E Z Yakupov · CyberLeninK (CyberLeninka) · 2014
[et al.] // Circulation. — 2007. — Vol. 115(20). — P.2637—2641. 11. The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): Rationale, Design, and Baseline Patient Characteristics / B. Massie, W. Krol, S. Ammon [et al.] // J. Cardiac. Fail. — 2004. — Vol. 10. — P.101—109.12. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm / H. Shunichi, L.P. John, J. Patrick [et al.] // N. Engl. J. Med. — 2012. — Vol. 366. — P.1859—1869. 13. Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study / D.V. Cokkinos, G.C. Haralabopoulos, J.B. Kostis [et al.] // Eur. J. Heart Fail. — 2006. — Vol. 8. — P.428—432.14. Antiplatelet Trialists’ Collaboration Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients // BMJ. — 1994. — Vol. 308. — P.235—246.15. Aspirin for preventing the recurrence of venous thromboembolism / C. Becattini, G.A. Agnelli, A. Schenone // N. Engl. J. Med. — 2012. — Vol. 366. — P.1959—1967.16. Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies / S. Birocchi, E. Scannella, L. Ferrari, G. M.Podda // Intern. Emerg. Med. — 2013. — Vol. 8. — P. 757—760.17. Nacional'nye rekomendacii VNOK i OSSN po diagnostike i lecheniyu HSN (III peresmotr) [National guidelines GFCF and PRAs for diagnosis and treatment of CHF (III revision)] / V.Yu. Mareev, F.T. Ageev, G.P. Arutyunov [I dr.] // Zhurnal serdechnaya nedostatochnost' [Journal of Heart failure]. — 2010. — № 1(57). — S.3—62.© А.Р. Хакимова, Н.А. Попова, Э.З. Якупов, 2014УДК 616.833.24-002-031.14:618.3
Cited by 0 works.